These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21920138)

  • 1. Part VII. Interventions.
    Visser A; Moore DP; Whitelaw A; Lowman W; Kantor G; Hoosen A; Madhi S; Brink A; van den Bergh D; Devenish L; Moodley P; Apalata T; Duse AG; Gelband H
    S Afr Med J; 2011 Jul; 101(8 Pt 2):587-95. PubMed ID: 21920138
    [No Abstract]   [Full Text] [Related]  

  • 2. Part V. Surveillance activities.
    Bamford C; Brink A; Govender N; Lewis DA; Perovic O; Botha M; Harris B; Keddy KH; Gelband H; Duse AG
    S Afr Med J; 2011 Jul; 101(8 Pt 2):579-82. PubMed ID: 21920136
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial Resistance: Challenges and the Way Forward.
    Shariff M
    Indian J Chest Dis Allied Sci; 2016 Jul; 58(3):157-159. PubMed ID: 30152647
    [No Abstract]   [Full Text] [Related]  

  • 4. A multi-society position paper on the prevention and management of nosocomial and severe infections: the Italian Society for Infectious Diseases, the Italian Multidisciplinary Society of Hospital Infections, the Italian Society of Chemotherapy, the Italian Society of Respiratory Medicine, the Italian Society of Clinical Microbiology, the Italian Society of Microbiology, and GISIG (Italian Study Group on Severe Infections).
    Ippolito G; Carosi G; Moroni M; Nicastri E; Lauria FN; Mazzotta F; Goglio A; Pea F; Blasi F; Fortina G; Rossano F
    Int J Infect Dis; 2010 Oct; 14 Suppl 4():S93-4. PubMed ID: 20708953
    [No Abstract]   [Full Text] [Related]  

  • 5. Part IV. Human infections and antibiotic resistance.
    Crowther-Gibson P; Govender N; Lewis DA; Bamford C; Brink A; von Gottberg A; Klugman K; du Plessis M; Fali A; Harris B; Keddy K; Botha M
    S Afr Med J; 2011 Jul; 101(8 Pt 2):567-78. PubMed ID: 21920135
    [No Abstract]   [Full Text] [Related]  

  • 6. Part VI. Antibiotic management and resistance in livestock production.
    Henton MM; Eagar HA; Swan GE; van Vuuren M
    S Afr Med J; 2011 Jul; 101(8 Pt 2):583-6. PubMed ID: 21920137
    [No Abstract]   [Full Text] [Related]  

  • 7. Part III. Antibiotic supply chain and management in human health.
    Essack SY; Schellack N; Pople T; van der Merwe L; Suleman F; Meyer JC; Gous AG; Benjamin D
    S Afr Med J; 2011 Jul; 101(8 Pt 2):562-6. PubMed ID: 21920134
    [No Abstract]   [Full Text] [Related]  

  • 8. Microbial disease trends and acquired antibiotic resistance: Part 1.
    Molinari JA
    Compend Contin Educ Dent; 1997 Feb; 18(2):106-8. PubMed ID: 9452530
    [No Abstract]   [Full Text] [Related]  

  • 9. Back from the dead. Emerging and re-emerging infectious diseases.
    Cornell S
    Adv Nurse Pract; 1998 May; 6(5):67-8. PubMed ID: 9633297
    [No Abstract]   [Full Text] [Related]  

  • 10. Infective disorders.
    Lahiri A
    J Indian Med Assoc; 2000 Jul; 98(7):367. PubMed ID: 11143854
    [No Abstract]   [Full Text] [Related]  

  • 11. Infection services in the intensive care unit.
    Gould IM; Carlet J
    Clin Microbiol Infect; 2000 Aug; 6(8):442-4. PubMed ID: 11168175
    [No Abstract]   [Full Text] [Related]  

  • 12. Executive summary: global antimicrobial resistance alerts and implications.
    Alliance for the Prudent Use of Antibiotics
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S221-3. PubMed ID: 16032555
    [No Abstract]   [Full Text] [Related]  

  • 13. Infection control: the case for horizontal rather than vertical interventional programs.
    Wenzel RP; Edmond MB
    Int J Infect Dis; 2010 Oct; 14 Suppl 4():S3-5. PubMed ID: 20851010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the laboratory in choosing antibiotics.
    Coghe F; Orrù G; Pautasso M; Ferraguti P; Sanna P; Fanos V
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():18-20. PubMed ID: 21740333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious diseases: back to the future?
    Hagan P; Projan S; Rosamond J
    Trends Microbiol; 2002; 10(10 Suppl):S1-2. PubMed ID: 12377560
    [No Abstract]   [Full Text] [Related]  

  • 16. Beginning and possibly the end of the antibiotic era.
    Ashkenazi S
    J Paediatr Child Health; 2013 Mar; 49(3):E179-82. PubMed ID: 23252836
    [No Abstract]   [Full Text] [Related]  

  • 17. Time to deal with antibiotics.
    Kennedy D
    Science; 2013 Nov; 342(6160):777. PubMed ID: 24233692
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation of national schistosomiasis control programmes in West Africa.
    Garba A; Touré S; Dembelé R; Bosque-Oliva E; Fenwick A
    Trends Parasitol; 2006 Jul; 22(7):322-6. PubMed ID: 16690357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant bacteria.
    Sowole L; Ming DK; Davies F
    Br J Hosp Med (Lond); 2018 May; 79(5):C66-C69. PubMed ID: 29727225
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems in the clinical use of antibiotics in China].
    Zhang YX
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):353-4. PubMed ID: 15558845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.